This item requires a subscription to Journal of Pharmacology and Experimental Therapeutics.
Cover
Full Text
GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL:
  • E. Lindström,
  • A. Ravnefjord,
  • M. Brusberg,
  • S. Hjorth,
  • H. Larsson,
  • and V. Martinez
The Selective 5-Hydroxytryptamine 1A Antagonist, AZD7371 [3(R)-(N,N-Dicyclobutylamino)-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide (R,R)-tartrate Monohydrate] (Robalzotan Tartrate Monohydrate), Inhibits Visceral Pain-Related Visceromotor, but Not Autonomic Cardiovascular, Responses to Colorectal Distension in Rats J Pharmacol Exp Ther June 2009 329:1048-1055; published ahead of print March 26, 2009, doi:10.1124/jpet.109.152330
To view this item, select one of the options below:

This Article

  1. Published online before print March 26, 2009, doi: 10.1124/jpet.109.152330 JPET June 2009 vol. 329 no. 3 1048-1055
  1. AbstractFree
  2. » Full Text
  3. Full Text (PDF)
  4. All Versions of this Article:
    1. jpet.109.152330v1
    2. 329/3/1048 most recent

Responses

  1. Submit a response
  2. No responses published

Current Issue

  1. November 2009, 331 (2)
  1. Current Issue
  1. Alert me to new issues of JPET